Skip to main content

Peer Review reports

From: Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?

Original Submission
3 Jan 2017 Submitted Original manuscript
17 Jan 2017 Reviewed Reviewer Report - Francesco Perrone
20 Jan 2017 Reviewed Reviewer Report - Charles Butts
27 Jan 2017 Author responded Author comments - Jordi Remon
Resubmission - Version 2
27 Jan 2017 Submitted Manuscript version 2
3 Feb 2017 Reviewed Reviewer Report - Francesco Perrone
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
16 Feb 2017 Editorially accepted
13 Mar 2017 Article published 10.1186/s12916-017-0819-3

You can find further information about peer review here.

Back to article page